Application 212795
- Type
- ANDA
- Sponsor
- TENSHI
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | LORATADINE | LORATADINE | TABLET, ORALLY DISINTEGRATING;ORAL | 5MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A212795-001 | LORATADINE | LORATADINE | 5MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2020-09-18 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A212795-001 | LORATADINE | 5MG | TABLET, ORALLY DISINTEGRATING / ORAL | 2020-09-18 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| LORATADINE | LORATADINE | CVS PHARMACY, INC | 4e74e322-7f6e-467c-96c0-9b531ddb429b | 2024-12-31 | Warnings | 212795 ANDA212795 51316-502 |
| Allervarx | LORATADINE | Innovus Pharmaceuticals, Inc. | ec4d1e77-6995-4228-8e63-a9ab6232dace | 2024-12-27 | Warnings | 212795 ANDA212795 57483-955 |
| Loratadine | LORATADINE | Tenshi Kaizen Pvt Ltd | c20b91e0-ef92-6f2f-e053-2a95a90a2a36 | 2024-01-02 | Warnings | 212795 ANDA212795 72983-500 |
| LORATADINE | LORATADINE | Strides Pharma Inc | a54cdbe9-32ec-45ca-948f-9cefbb8e3cbf | 2024-01-02 | Warnings | 212795 ANDA212795 59556-301 |
| Loratadine | LORATADINE | Walgreens Company | 8229ca40-31cf-3dbd-078d-364f5674cb21 | 2023-02-27 | Warnings | 212795 ANDA212795 |
| Loratadine | LORATADINE | Dr. Reddy's Laboratories Inc. | 9357186a-9452-e139-01d8-6b8c6f6a2c6b | 2023-02-24 | Warnings | 212795 ANDA212795 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 51316-502 | LORATADINE | LORATADINE | CVS PHARMACY, INC | ANDA | Current |
| 57483-955 | Allervarx | Loratadine | Innovus Pharmaceuticals, Inc. | ANDA | Current |
| 59556-301 | LORATADINE | LORATADINE | Strides Pharma Inc | ANDA | Current |
| 59556-301 | LORATADINE | LORATADINE | Strides Pharma Inc | ANDA | Current |
| 59556-301 | LORATADINE | LORATADINE | Strides Pharma Inc | ANDA | Current |
| 72983-500 | Loratadine | Loratadine | Tenshi Kaizen Pvt Ltd | ANDA | Current |
| 72983-500 | Loratadine | Loratadine | Tenshi Kaizen Pvt Ltd | ANDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 65101 | ORIG | 2020-10-30 |